Registry › XF-NHU0S9D-P
XF-NHU0S9D-P
Second Party Opinion ACTIVE

ISS ESG Second Party Opinion — Teva Pharmaceutical Industries Ltd.

Document Metadata

Issuer
Teva Pharmaceutical Industries Ltd.
Document Type
Second Party Opinion
Publication Year
2021
Retrieved
20 March 2026
Source
Contact XFID for Access
Record ID
XFNHU0S9DP
Validation
Inferred by XFID

Verification

XFIDs are content-addressed: these SHA-256 fingerprints let anyone confirm a copy of this document is identical to what XFID retrieved on 20 March 2026 — independent of this registry.

SHA-256 (file bytes)
07206efa37f3a92f27648de5317a1238a1fcb171a1ce444ff6c67dd466d86fb8
SHA-256 (canonical content)
e6583f91db9026a7c3c1627a00b7ef0783949323a63639ba2931179e62b25766
File
1092 KB

The canonical-content hash survives re-downloads, URL moves, and byte-level re-encodes: the same disclosure text always resolves to this XFID.

Assessment Provider

ISS ESG Provider

People Cited in This Document

Version History

Retrieved Action Size
20/03/2026 INITIAL 1092 KB latest

How to Cite This Record

Use the XFID in citations to create a stable, permanent reference that resolves to this registry entry regardless of the source URL.

Academic / report citation
Teva Pharmaceutical Industries Ltd. (2021). ISS ESG Second Party Opinion — Teva Pharmaceutical Industries Ltd.. XFID: XF-NHU0S9D-P. Retrieved from https://xframework.id/XFNHU0S9DP
Identifier only
XF-NHU0S9D-P